Sildenafil for Treatment of Priapism in Men With Sickle Cell Anemia
Status:
Completed
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
This research is being done to evaluate if the phosphodiesterase type 5 (PDE5) inhibitor
sildenafil has an effect on the frequency of recurrent priapism and the quality of life of
males with sickle cell disease (SCD).